So would a break between cohorts from now on of 3-4 weeks sound about right?

RE: the email alert today from CEO, I cannot make heads of tails of it so will wait for those that understand it to pass on their take on the situation.  If Leo got us into it, I'm pretty much for it, sight unseen as Dr D (from the Sci. Adv. Board) is the super pro on drugs and Leo would know if the fit is good for CTIX.  My main question is what is CTIX bringing to the table with this deal should it go thru?

Also, besides Dr D we have Dr Marks on the Sci Adv Board and he was CEO and Pres. of Sloan-Kettering for 19 years and is still Pres. Emeritus.  Pretty good contacts.